Alyeska Investment Group’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$277M Buy
2,305,574
+728,862
+46% +$84.1M 0.78% 14
2025
Q4
$166M Buy
+1,576,712
New +$148M 0.47% 41
2024
Q2
Sell
-27,057
Closed -$3.57M 635
2024
Q1
$3.57M Buy
+27,057
New +$3.33M 0.02% 350
2022
Q3
Sell
-4,604
Closed -$420K 448
2022
Q2
$420K Buy
+4,604
New +$408K ﹤0.01% 535
2021
Q4
Sell
-1,049,203
Closed -$78.8M 687
2021
Q3
$78.8M Buy
1,049,203
+517,525
+97% +$39.4M 0.97% 11
2021
Q2
$41.3M Buy
+531,678
New +$39.5M 0.48% 57
2018
Q1
Sell
-1,834,974
Closed -$98.5M 487
2017
Q4
$98.5M Sell
1,834,974
-108,545
-6% -$6.02M 0.78% 38
2017
Q3
$119M Buy
+1,943,519
New +$118M 0.89% 22
2016
Q4
Sell
-1,683,390
Closed -$100M 517
2016
Q3
$100M Buy
1,683,390
+1,562,505
+1,293% +$91.4M 0.93% 12
2016
Q2
$6.64M Sell
120,885
-244,480
-67% -$13M 0.06% 286
2016
Q1
$18.4M Sell
365,365
-1,141,279
-76% -$55.9M 0.17% 185
2015
Q4
$75.9M Buy
+1,506,644
New +$76M 0.81% 29
2014
Q3
Sell
-486,434
Closed -$26.9M 430
2014
Q2
$26.9M Buy
486,434
+133,097
+38% +$7.26M 0.6% 37
2014
Q1
$19.1M Buy
+353,337
New +$18.3M 0.53% 61
2013
Q4
Sell
-20,960
Closed -$958K 352
2013
Q3
$952K Buy
+20,960
New +$957K 0.04% 261

Other funds holding MRK

Alyeska Investment Group's MRK Position: Q1 2026 in Review

Alyeska Investment Group increased its Merck (MRK) stake by 46% in Q1 2026, buying an estimated $84.1M and bringing the position to 2,305,574 shares worth $277M. The position accounts for 0.78% of the portfolio, ranked #14.

Alyeska Investment Group first reported a position in MRK in Q3 2013 and has held it in 15 quarters since. 3,777 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Alyeska Investment Group held 2,305,574 shares of Merck worth $277M as of Q1 2026.
  • Alyeska Investment Group bought 728,862 Merck shares in Q1 2026, an estimated $84.1M.
  • Merck made up 0.78% of Alyeska Investment Group's portfolio in Q1 2026, its #14 holding.
  • Alyeska Investment Group first reported a position in Merck in Q3 2013 and has held it in 15 quarters since.
  • 3,777 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Alyeska Investment Group's 13F filing for Q1 2026, filed 15 May 2026.